SRA Awarded $98 Million Contract from Food and Drug Administration
January 19 2010 - 4:01PM
Business Wire
SRA International, Inc. (NYSE: SRX), a leading provider of
technology and strategic consulting services and solutions to
government organizations and commercial clients, today announced
that, on behalf of the Food and Drug Administration (FDA), the
Department of the Interior/National Business Center/Acquisition
Services Directorate-Herndon has awarded SRA the Mission
Accomplishment and Regulatory Compliance Services (MARCS)
Integration Contract (MIC). The single-award indefinite delivery,
indefinite quantity contract has a total ceiling value of $98
million over a five-year period of performance.
Under the contract, SRA will work with FDA’s Offices of
Regulatory Affairs (ORA) and Information Management to design,
develop and implement IT solutions that better automate field
operations (domestic and foreign) such as inspections, sample
collection and analysis, import screening and review, recalls, and
their relationships with compliance activities, as well as the work
planning, scheduling, and performance information related to those
activities and their management.
“FDA plays a central role in protecting the American public with
respect to food safety, drugs and other products that it
regulates," said SRA Health & Civil Services Senior Vice
President Max Hall. “This is a major opportunity to assist FDA in
meeting its rapidly expanding responsibilities for public health
and safety, and we look forward
to providing improved tools that
will help them carry out this significant mission every
day.”
The contract is intended to help FDA enhance its capabilities to
meet congressional mandates and public expectations. Food safety
violations resulting in threats to public health are front-page
news, and domestic as well as imported products that FDA regulates
pose a greater threat to the nation than ever
before. Legislation such as the Food and Drug Administration
Amendments Act of 2007 and the pending Food Safety Enhancement Act
have expanded FDA’s regulatory authority to address these concerns,
and have also expanded the workload of ORA.
SRA MARCS partners include Emergint, Inc.; Everware CBDI;
Guident Technologies; IntegrityOne Partners; Mythics, Inc.; NTELX;
Neilson Consulting; and Quality Resource Systems, Inc.
About SRA International, Inc.
SRA and its subsidiaries are dedicated to solving complex
problems of global significance for government organizations
serving the national security, civil government and global health
markets. Founded in 1978, the company and its subsidiaries have
expertise in such areas as air surveillance and air traffic
management; contract research organization (CRO) services; cyber
security; disaster response planning; enterprise resource planning;
environmental strategies; IT systems, infrastructure and managed
services; logistics; public health preparedness; public safety;
strategic management consulting; systems engineering; and wireless
integration.
FORTUNE® magazine has chosen SRA as one of the “100 Best
Companies to Work For” for ten consecutive years. The company and
its subsidiaries employ more than 6,900 employees serving clients
from headquarters in Fairfax, Va., and offices around the world.
For additional information on SRA, please visit www.sra.com.
Any statements in this press release about future expectations,
plans, and prospects for SRA, including statements about the
estimated value of the contract and work to be performed, and other
statements containing the words “estimates,” “believes,”
“anticipates,” “plans,” “expects,” “will,” and similar expressions,
constitute forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements. In addition, the forward-looking statements included in
this press release represent our views as of Jan. 19, 2010. We
anticipate that subsequent events and developments will cause our
views to change. However, while we may elect to update these
forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so. These
forward-looking statements should not be relied upon as
representing our views as of any date subsequent to Jan. 19,
2010.
Sra (NYSE:SRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sra (NYSE:SRX)
Historical Stock Chart
From Jul 2023 to Jul 2024